Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 3;9(4):546-550.
doi: 10.1002/mdc3.13453. eCollection 2022 May.

Pembrolizumab-Induced Steroid-Responsive Myoclonus

Amy Gallagher  1 , Michael Murphy  1 , Ray McDermott  2 , Michael Alexander  3 , Sean O'Dowd  1   4
Affiliations
Case Reports

Pembrolizumab-Induced Steroid-Responsive Myoclonus

Amy Gallagher et al. Mov Disord Clin Pract. .
No abstract available

Keywords: Pembrolizumab; adverse; immune checkpoint inhibitor; myoclonus; neurological.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Illustration of the patient's clinical timeline.
See this image and copyright information in PMC

References

    1. Zekeridou A, Kryzer T, Guo Y, Hassan A, Lennon V, Lucchinetti C, et al. Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity. Neurology 2019;93(8):e815–e822. - PMC - PubMed
    1. Cho J, Kim H, Ku B, Choi Y, Cristescu R, Han J, et al. Pembrolizumab for patients with refractory or relapsed Thymic epithelial tumor: An open‐label phase II trial. J Clin Oncol 2019;37(24):2162–2170. - PubMed
    1. Kao J, Liao B, Markovic S, Klein C, Naddaf E, Staff N, et al. Neurological complications associated with anti–programmed death 1 (PD‐1) antibodies. JAMA Neurol 2017;74(10):1216–1222. - PMC - PubMed
    1. Wang Y, Zhou S, Yang F, et al. Treatment‐related adverse events of PD‐1 and PD‐L1 inhibitors in clinical trials. JAMA Oncol 2019;5(7):1008–1019. - PMC - PubMed
    1. Fan S, Ren H, Zhao L, Yin J, Feng G, Wang J, Guan H. Neurological immune‐related adverse events associated with immune checkpoint inhibitors: A review of the literature. Asia Pac J Clin Oncol 2020;16(6):291–298. - PubMed

Publication types

LinkOut - more resources